India  

Covaxin booster beats back Delta, Omicron variants: NIV

IndiaTimes Thursday, 16 June 2022
The researchers compared the efficacy of Covaxin after the second and third doses against the Delta variant, and also studied its efficacy against the Omicron variants in a Syrian hamster model.
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

SARS-CoV-2 Omicron variant SARS-CoV-2 Omicron variant A variant of SARS-CoV-2 first detected in November 2021

After 6 months, city Covid cases cross 2k mark; 5 die in a day

The number of new Covid-19 cases in the city crossed the 2,000-mark on Wednesday, with five patients succumbing to the deadly virus. The last time the city..
IndiaTimes
Global Governments Bracing for Future Waves of COVID Variants [Video]

Global Governments Bracing for Future Waves of COVID Variants

Global Governments , Bracing for Future Waves , of COVID Variants. Fox reports that governments and populations alike are bracing as the third winter of the coronavirus pandemic looms for the northern hemisphere. Chris Murray, head of the Institute of Health Metrics and Evaluation (IHME), warns that there could be up to a million new infections a day in the United States alone. . With nearly no masking or social distancing restrictions in place, the United Kingdom and Europe predicts a series of COVID waves. Experts say that while cases may surge again in the coming season, deaths and hospitalizations are unlikely to rise as sharply. The people who are at greatest risk are those who have never seen the virus, and there's almost nobody left, Chris Murray, head of the Institute of Health Metrics and Evaluation (IHME), via Fox. According to Fox, these predictions raise new questions regarding when the COVID pandemic will finally end and enter a state of endemic disease. Many experts predicted that transition would occur early in 2022, however the emergence of the omicron variant derailed those forecasts. Anyone who says they can predict the future of this pandemic is either overconfident or lying, David Dowdy, Infectious disease epidemiologist at Johns Hopkins Bloomberg School of Public Health. The World Health Organization warns that each country will need to approach new waves of COVID with all the means at their disposal. This includes everything from vaccinations to interventions, such as social distancing or masking protocols and broad testing.

Credit: Wibbitz Top Stories    Duration: 01:30Published
Covid-19 update: India logs 16,935 new cases and 51 deaths in last 24 hours | Oneindia News *News [Video]

Covid-19 update: India logs 16,935 new cases and 51 deaths in last 24 hours | Oneindia News *News

According to the Union Health ministry's data, India added 16,935 Covid cases and 51 Covid-related deaths in the last 24 hours. #CovidIndia #Covid19 #CovidCases #CoronaDeaths India, Omicron, BA.4 sub-variant, New Covid cases, Active cases, Daily new cases, Covid fatalities, Delta plus variant, Corona second wave, Corona third wave, Corona recovery rate, Weekly positivity rate, Covid tests done, Coronavirus case count, India, Covid vaccination drive, Omicron alert, Covid guidelines, Oneindia English, Oneindia News.

Credit: Oneindia    Duration: 01:18Published
Are BA.5 Patients More Likely To Lose Sense of Smell? [Video]

Are BA.5 Patients More Likely To Lose Sense of Smell?

Are BA.5 Patients More Likely , To Lose Sense of Smell?. NBC News reports doctors in the United States say that with the rise of the BA.5 subvariant, . peculiar symptoms of coronavirus may be making a comeback. Most noticeably, health care providers say many patients once again report a loss of smell. What I am seeing in my corner of the world is a spike. , Valentina Parma, psychologist, Monell Chemical Senses Center of Philadelphia, via NBC News. As the coronavirus pandemic lingers on, new variants and subvariants have appeared less likely to cause a loss of smell than previous ones. One study found that the Alpha variant, the first variant which caused concern among health care providers. was 50% less likely to impair smell than the original strain of coronavirus. In comparison, the Delta variant only caused about 44% of patients to lose their sense of smell. During the first Omicron wave, only 17% of patients reported a loss of smell. During the first Omicron wave, only 17% of patients reported a loss of smell. Still early in the wave of the BA.5 subvariant, experts say evidence of loss of smell is based on personal accounts rather than facts. I have talked to people overall about losing their taste and smell lately and it seems that there is an uptick, but the data isn’t there yet. , Dr. Lora Bankova, allergist and immunologist Brigham, Women's Hospital of Boston, via NBC News

Credit: Wibbitz Top Stories    Duration: 01:30Published
How the BA.5 Subvariant Could Affect the US [Video]

How the BA.5 Subvariant Could Affect the US

How the BA.5 Subvariant , Could Affect the US. BA.5, a subvariant of Omicron, is now the most dominant strain of COVID in the U.S. Data shows that it is the most transmissible variant of the coronavirus to date, and it can even infect those who have recently recovered from illness. I think there’s an underappreciation of what it’s going to do to the country, and it already is exerting its effect, Eric Topol, Professor of Molecular Medicine at Scripps Research, via 'The New York Times'. Federal data and data from the CDC shows that infections are up in the U.S. In tandem with the BA.4 subvariant, the BA.5 subvariant has caused an increase in hospitalizations. Neither subvariant seems to be a more severe version of the coronavirus. Experts say that while prior immunity as a result of previous infection and vaccination appears to help prevent severe illness, . the level of protection seems to be less robust. It’s not anything like what we would hope, Eric Topol, Professor of Molecular Medicine at Scripps Research, via 'The New York Times'. In other countries with high vaccination rates, the BA.5 variant has led to a spike in hospitalizations. Countries that have recently experienced a wave during the spring are also reporting increased infections. While experts say it's too early to predict what these new subvariants will mean for the U.S.. there is wide agreement that the BA.5 wave is already in effect. There’s a wave afoot, there’s no question about it. My concern is the length of it, Eric Topol, Professor of Molecular Medicine at Scripps Research, via 'The New York Times'

Credit: Wibbitz Top Stories    Duration: 01:31Published

Covaxin Covaxin Vaccine against COVID-19

Govt panel recommends Corbevax as booster for adults vaccinated with Covishield, Covaxin

government panel on Covid immunisation has recommended allowing Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield..
IndiaTimes
Bharat Biotech’s Covaxin safe for children of  2to18 years says Lancet Journal Oneindia News*News [Video]

Bharat Biotech’s Covaxin safe for children of 2to18 years says Lancet Journal Oneindia News*News

The manufacturers of the Covid-19 vaccine Covaxin, Bharat Biotech have said that their vaccine is safe for use on children between the age group of 2 to 18 years. #Covaxin #BharatBiotech #LancetJournal

Credit: Oneindia    Duration: 01:41Published
COVAXIN BOOSTER DOSE: EFFECTIVE AGAINST OMICRON AND DELTA VARIANT| OneIndia News* News [Video]

COVAXIN BOOSTER DOSE: EFFECTIVE AGAINST OMICRON AND DELTA VARIANT| OneIndia News* News

ICMR and Bharat biotech has found in a study that Covaxin booster dose is highly effective against delta and omicron variants. Lung disease, virus shedding and are reduced after the third dose of Covaxin. #covidupdate #covaxin #boosterdose

Credit: Oneindia    Duration: 01:41Published

You Might Like


Related videos from verified sources

FDA Calls for Fall COVID Boosters To Target Omicron Subvariants [Video]

FDA Calls for Fall COVID Boosters To Target Omicron Subvariants

FDA Calls for Fall COVID Boosters , To Target Omicron Subvariants. NBC News reports that on June 30, the Food and Drug Administration asked vaccine makers to modify upcoming booster shots to target..

Credit: Wibbitz Top Stories     Duration: 01:30Published
Moderna Says New Booster Shows 'Superior' Omicron Response [Video]

Moderna Says New Booster Shows 'Superior' Omicron Response

Moderna Says New Booster , Shows 'Superior' Omicron Response. NPR reports Moderna claims its most recent vaccine candidate has shown a "superior neutralizing antibody response" when compared to its..

Credit: Wibbitz Top Stories     Duration: 01:30Published

Related news from verified sources

Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR study

The protective efficacy of Bharat Biotech's Covaxin following two and three-dose immuniszations against the Delta variant and the efficacy of the Covaxin against...
IndiaTimes

NTAGI to discuss allowing Corbevax as booster shot for Covishield, Covaxin recipients: Sources

Allowing Biological E's Corbevax as a booster for those fully vaccinated against Covid-19 with either Covishield or Covaxin and reducing the gap between the...
IndiaTimes Also reported by •DNA